Discovering the First Genetic Marker for Bone Tumor

Osteoblastoma: Scientists at the Wellcome Sanger Institute and their collaborators at the UCL Cancer Institute and Francis Crick Institute have discovered a genetic mutation that distinguishes osteoblastoma (benign) from osteosarcoma (aggressive)

Share: